CPB vs ERNA · P/E 12, rev $10.25B vs P/E 0.0, rev $582.0K
Campbell’s Co (CPB) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
Campbell’s Co (CPB) is a packaged foods company listed on US.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported CPB revenue for 2025-08-03 was $10.25B. Net income was $602.0M. Revenue was up 6.4% from 2024-07-28 to 2025-08-03. CPB currently screens at market cap $6.46B and trailing P/E 11.8.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
CPB currently screens at market cap $6.46B and trailing P/E 11.8. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the CPB and ERNA stock pages for the full models.
Not investment advice.